Effect of nitrofurantoin and methenamine hippurate prophylaxis on bacteria and yeasts in the urine of patients with an indwelling catheter.
D000368:Aged; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use*; D001419:Bacteria / Q000302:isolation & purification; D001437:Bacteriuria / Q000517:prevention & control; D002986:Clinical Trials as Topic; D005260:Female; D006626:Hippurates / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008709:Methenamine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009582:Nitrofurantoin / Q000627:therapeutic use*; D014546:Urinary Catheterization; D014552:Urinary Tract Infections / Q000382:microbiology / Q000517:prevention & control*; D015003:Yeasts / Q000302:isolation & purification
D000892:Anti-Infective Agents, Urinary; D006626:Hippurates; D009582:Nitrofurantoin; D008709:Methenamine; C011481:methenamine hippurate